- The South African Health Products Regulatory Authority reportedly would like to stop the pause on the J&J Covid-19 vaccine
- Sahpra believes that there should be conditions involved if and when the vaccine usage is reinstated
- Sahpra also reviewed data from Johnson & Johnson's local research where it stated that there were no significant safety concerns
On Saturday, the South African Health Products Regulatory Authority (Sahpra) proposed that the government terminate the pause on the administering of the Johnson & Johnson's Covid-19 vaccines, provided that certain conditions are met.
One of these conditions insists on improved screening and monitoring of recipients who pose a high risk of blood clotting.
Sahpra stated on Wednesday that there were no significant safety concerns discovered based on recently reviewed data from Johnson & Johnson’s local research study immunising healthcare workers.
Following reports made by IOL, a US panel will gather again next week to discuss whether the halt on the use of the vaccine should remain. This after six people out of the almost 7 million people who were vaccinated were discovered to have rare cases of blood clots.
According to TimesLIVE, acknowledgement of the newly discovered side effect will be disclosed on the information sheets and the informed consent forms signed before vaccination is administrated.
Previously, Briefly News reported that Health Minister Dr Zweli Mkhize revealed that the Johnson & Johnson Covid-19 vaccine rollout will be voluntarily suspended in South Africa. This follows news of six women in the United States developing 'unusual' blood clots.
The Food and Drug Administration (FDA) in the US temporarily suspended the vaccine rollout within the country due to the blood clots found. Reports say that the incidents surfaced between six and 13 days after the women received the vaccination.
The ladies were aged between 18 and 48 years old. That being said, there have been over 7 million US citizens who had received the Johnson & Johnson Covid-19 vaccine. The health minister also revealed that out of the over 280 000 South African health care workers who have received the J&J vaccine there have been no reports of any blood clots formed post-vaccination.
Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!